Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Affiliations

• ¹ Ian M. Burr Division of Pediatric Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, TN [email protected].
• ² Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
• ³ Ian M. Burr Division of Pediatric Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, TN.
• ⁴ Division of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.
• ⁵ Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN.
• ⁶ Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN.
• ⁷ Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA.